Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies

Pain and Therapy
Rosaria Del GiornoStefano Coaccioli

Abstract

Fibromyalgia syndrome (FM) is characterized by persistent pain which is often refractory to common analgesic therapies and is particularly disabling. The objective of this study was to evaluate the therapeutic efficacy of duloxetine (DLX) + pregabalin (PGB) in patients suffering from FM and the possible added benefit of the lipid signaling molecule, palmitoylethanolamide (PEA). PEA is well-documented to exert anti-inflammatory, analgesic, and pain-relieving effects at both the preclinical and clinical level. A total of 80 patients were recruited in two steps. The first was a retrospective observational study comprising 45 patients. This patient group received DLX + PGB for 6 months. The second step was a prospective observational study with 35 patients. Patients in this cohort began treatment with DLX + PGB at the same dosage as for the retrospective study plus micronized PEA (PEA-m(®); Epitech Group, Italy) and ultramicronized PEA (PEA-um(®); Epitech Group, Italy) for 3 months. Positive tender points (TPs), pain evoked, and pain intensity were evaluated at baseline and after 3 and 6 months in both studies. Statistical analyses were employed for comparison of data within the two studies and between them. The retrospective obser...Continue Reading

References

Jan 1, 1993·Agents and Actions·L AloeR Levi-Montalcini
Jul 10, 2003·Best Practice & Research. Clinical Rheumatology·Daniel J Clauw, Leslie J Crofford
Jul 14, 2005·Disability and Rehabilitation·Stefan Bergman
Aug 26, 2006·Nature Clinical Practice. Rheumatology·Roland Staud, Miguel E Rodriguez
Oct 17, 2007·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Lesley M Arnold
Apr 1, 2008·Pain Practice : the Official Journal of World Institute of Pain·Stefano CoaccioliAdolfo Puxeddu
Jan 15, 2009·JAMA : the Journal of the American Medical Association·Winfried HäuserClaudia Sommer
Aug 6, 2009·Handbook of Experimental Pharmacology·Richard J MillerFletcher A White
Jan 26, 2010·Biochimie·Stefania PetrosinoVincenzo Di Marzo
Apr 27, 2010·The Journal of Pain : Official Journal of the American Pain Society·Winfried HäuserClaudia Sommer
Jul 7, 2010·BMC Musculoskeletal Disorders·Sebastian StraubeHenry J McQuay
Aug 1, 2012·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Antonio GattiAlessandro Fabrizio Sabato
Jan 12, 2013·Science·Ira Tabas, Christopher K Glass
Jun 27, 2013·Current Pain and Headache Reports·Luiz Paulo Queiroz
Nov 2, 2013·Inflammopharmacology·Stephen D SkaperPietro Giusti
Jan 28, 2014·Immunology Letters·Ignasi Rodriguez-PintóYehuda Shoenfeld
Feb 6, 2014·The European Journal of Neuroscience·Livio LuongoVincenzo Di Marzo
Apr 17, 2014·JAMA : the Journal of the American Medical Association·Daniel J Clauw
Sep 6, 2014·Frontiers in Cellular Neuroscience·Caroline M Freitag, Richard J Miller
Mar 7, 2015·Progress in Molecular Biology and Translational Science·E Alfonso Romero-Sandoval, Sarah Sweitzer
Jun 3, 2015·The American Journal of Medicine·Morton E Tavel
Jun 10, 2015·Molecular Neurobiology·Stephen D SkaperPietro Giusti

❮ Previous
Next ❯

Citations

May 26, 2016·British Journal of Clinical Pharmacology·Linda GabrielssonChristopher J Fowler
Mar 10, 2018·Current Medical Research and Opinion·Lesley M ArnoldLloyd Knapp
Nov 22, 2017·Neurologia i neurochirurgia polska·Domenico ChirchigliaFrancesco Signorelli
Feb 14, 2019·Rheumatology International·Ilke Coskun Benlidayi
May 23, 2019·The American Journal of Hospice & Palliative Care·Mellar P DavisCarlos Fernandez
Jan 7, 2020·Pain and Therapy·Martina RekatsinaGiustino Varrassi
Sep 7, 2017·Pain Research and Treatment·Antonella PaladiniStefano Coaccioli
Apr 6, 2018·Frontiers in Cellular Neuroscience·Stephen D SkaperPietro Giusti
Jul 5, 2019·CNS & Neurological Disorders Drug Targets·Giorgio CruccuAndrea Truini
Dec 19, 2020·International Journal of Molecular Sciences·Stefania Petrosino, Aniello Schiano Moriello
Oct 29, 2020·SAGE Open Medicine·Céline BodéréAnais Le Fur-Bonnabesse
Feb 18, 2021·Pain and Therapy·Roberto CasaleAntonella Paladini
Apr 4, 2021·Animals : an Open Access Journal From MDPI·Giorgia Della Rocca, Davide Gamba
May 1, 2021·Journal of Clinical Medicine·Chun-Feng CaoHai-Qiang Wang
Jun 3, 2021·International Journal of Molecular Sciences·Paul ClaytonRuchitha Venkatesh
Sep 1, 2021·Expert Opinion on Pharmacotherapy·Joseph V PergolizziFlaminia Coluzzi
Apr 6, 2020·Journal of Vascular Research·Bruno A Marichal-CancinoCarlos M Villalón
Nov 30, 2021·Journal of Dietary Supplements·Paul ClaytonNathasha Bogoda

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.